Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FORENSIC TOXICOLOGY SOFTWARE FOR SCREENING DRUGS UNVEILED.
- Applied Biosystems and MDS SCIEX haVE developed a new, automated toxicology testing application designed for efficient identification of drugs of abuse, such as cocaine, heroin and date rape drugs for forensic investigations. This software application enables faster delivery of results, more thorough screening and, ultimately, more...
- Research articles 2007-11-01
- New Applied Biosystems Reagent Kit Improves DNA Analysis
- BigDye[R] XTerminator[TM] Purification Kit Simplifies Workflow for Sanger Sequencing Projects FOSTER CITY, Calif. -- Applied Biosystems (NYSE:ABI), an Applera Corporation Business, today announced a new reagent kit designed to improve the workflow for DNA sequencing. The BigDye[R] XTerminator[TM] Purification Kit addresses the often cumbersome purification or 'clean-up' step in...
- Research articles 2007-02-21
- Scientists Discover New Gene Associated with Crohn's Disease
- Applied Biosystems Genotyping Technologies Uncover New Support for Role of Abnormal Immune Response to Intestinal Bacteria in the Disease FOSTER CITY, Calif. & KIEL, Germany -- Scientists have discovered another piece of the genetic puzzle that may predispose humans to Crohn's disease, a complex disorder characterized by chronic inflammation...
- Research articles 2007-01-24
- Applied Biosystems Announces Collaboration with Eagle Research and Development
- Co-Development Work to Begin on Portable, Single Molecule Detection Device Capable of Rapid and Inexpensive Protein and DNA Analysis FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced that it has signed an agreement with Eagle Research and Development, LLC to collaborate on further...
- Research articles 2006-10-31
- Researchers Identify New Protein Biomarker Candidates That May Lead to Better Diagnosis and Treatment for Age-Related Diseases
- FOSTER CITY, Calif. -- Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies Targeted in Protein Study Enabled by Applied Biosystems/MDS SCIEX's Advanced Technologies Applied Biosystems (NYSE: ABI), an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc. (NYSE:MDZ, TSX:MDS), today announced the...
- Research articles 2006-08-23
- Applied Biosystems and GeneGo Collaborate to Advance Understanding of Tissue Gene Expression; GeneGo Integrates Applied Biosystems Tissue Gene Expression Database Into Its MetaCore™ Data Mining Platform
- FOSTER CITY, Calif. & St. Joseph, Mich. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, and GeneGo, Inc., a leading provider of software and databases for systems biology, today announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways. As part of the agreement,...
- Research articles 2006-08-03
- Applied Biosystems Innovation Enables Accurate, Quantitative Gene Expression Analysis of Very Small or Rare Samples; TaqMan® PreAmp Master Mix Kit Addresses Unmet Need to Generate Robust Real-Time PCR Results From Limited Amounts of RNA
- FOSTER CITY, Calif. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the launch of a commercial reagent mix that enables accurate, quantitative, real-time gene expression analysis on very small or rare samples. The TaqManR PreAmp Master Mix Kit is intended to address the challenge faced by researchers working...
- Research articles 2006-07-26
- Applied Biosystems to Webcast Investor Presentations on June 23
- FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast management presentations to be given on Friday, June 23, 2006 by executives of Applied Biosystems/MDS Sciex Instruments, a joint venture between Applied Biosystems and MDS Inc. Stephen P. DeFalco, President and Chief Executive Officer, MDS Inc.;...
- Research articles 2006-06-21
- Applied Biosystems/MDS Sciex Accelerates Drug Discovery with New Pharmaceutical Application
- FOSTER CITY, Calif. -- New LightSightTM Software for Metabolite Identification Increases the Effectiveness of Pharmaceutical Companies' Selection of Drug Candidates for Development Applied Biosystems (NYSE: ABI), an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc. (NYSE:MDZ, TSX:MDS), today announced the global availability...
- Research articles 2006-05-30
- Applied Biosystems Names TLV Kumar President for Asia Pacific Region; Veteran Executive to Lead Company's Growth Strategies Across Region
- HONG KONG & FOSTER CITY, Calif. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that TLV Kumar has been appointed president for its Asia Pacific operations. Applied Biosystems is a global leader in the life sciences industry and research community, developing and marketing instrument-based systems, consumables, software, and...
- Research articles 2006-05-23
- Celera Genomics Reports Third Quarter Fiscal 2006 Results
- ROCKVILLE, Md. -- Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $23.3 million, or $0.31 per share, for the third quarter of fiscal 2006 ended March 31, 2006, compared to a net loss of $21.0 million, or $0.29 per share, for the third quarter...
- Research articles 2006-04-27
- Applied Biosystems Expands Line of TaqMan® MicroRNA Assays; Nearly 300 Individual Assays for Human, Mouse, and Rat MicroRNAs Now Available Online
- FOSTER CITY, Calif & WASHINGTON -- Today at the 2006 Annual Meeting of the American Association for Cancer Research, Applied Biosystems (NYSE:ABI), an Applera Corporation business, announced the commercial availability of 300 individual TaqManR MicroRNA Assays also known as miRNA assays for human, mouse, and rat studies. MicroRNAs, one...
- Research articles 2006-04-04
- Applied Biosystems and SAIC-Frederick, Inc. to Collaborate on NCI-Funded Genotyping Studies for Cancer Research
- FOSTER CITY, Calif. & WASHINGTON -- Collaboration to Validate TaqManR Drug Metabolism Assays Using HapMap, SNP500Cancer, and Other Key Sample Sets for Pharmacogenetic Studies Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced at the 2006 Annual Meeting of the American Association for Cancer Research AACR that it has...
- Research articles 2006-04-04
- Applied Biosystems Completes Acquisition of the Research Products Division of Ambion, Inc
- FOSTER CITY, Calif. & AUSTIN, Texas -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, announced today that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid RNA, the central...
- Research articles 2006-03-02
- Applied Biosystems Advanced Gene Expression Service Provider Program Expands Globally; Researchers in North America, Europe, and Asia Outsource Comprehensive Gene Expression Analysis Using Applied Biosystems Expression Array System
- FOSTER CITY, Calif. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced its Advanced Gene Expression Service Provider Program has expanded globally with the addition of eleven microarray service provider centers throughout North America, Europe, and Asia. As part of their participation, the eleven companies and academic centers...
- Research articles 2006-02-09
- Celera Genomics Reports Second Quarter Fiscal 2006 Results
- ROCKVILLE, Md. -- Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $17.3 million, or $0.23 per share, for the second quarter of fiscal 2006 ended December 31, 2005, compared to a net loss of $19.4 million, or $0.27 per share, for the second quarter...
- Research articles 2006-01-25
- Celera Genomics Acquires Full Ownership of Celera Diagnostics Joint Venture; Celera Genomics to Partner or Sell Small Molecule Drug Development Programs
- ROCKVILLE, MD -- Strategy to Reduce Cash Burn Substantially and Accelerate Move to Profitability; Conference Call at 10 a.m. EST Tomorrow
- Research articles 2006-01-10
- Applied Biosystems Transfers Its Interest in Celera Diagnostics to Celera Genomics in Exchange for Various Considerations and Cash
- FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI):
- Research articles 2006-01-10
- Applied Biosystems to Acquire the Research Products Division of Ambion, Inc., a Premium Provider of Innovative RNA-Based Consumables
- FOSTER CITY, Calif. & AUSTIN, Texas -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and Ambion, Inc. today announced they have signed a definitive agreement whereby Applied Biosystems will acquire the Research Products Division of Ambion, a premium supplier of RNA-based reagents for life science research and drug development,...
- Research articles 2005-12-27
- Applied Biosystems Completes Equity Investment in VisiGen Biotechnologies
- FOSTER CITY, Calif. & HOUSTON -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, announced today that it has completed its previously announced equity investment in privately held VisiGen Biotechnologies, a next-generation sequencing technology company. Concurrent with its investment, Applied Biosystems also entered into a scientific collaboration agreement with VisiGen....
- Research articles 2005-12-08
- << Previous
- page 1 of 4
- Next >>
Refining Tags
